Tereos   Report issue

For profit
Founded: Lille France (1999)
Status: No NME R&D (1999)

Organization Overview

First Clinical Trial
2009
NCT00806104
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Syral | Tereos

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 7
  • # of Trial APIs: 7